Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients.

Menon DV, Arbique D, Wang Z, Adams-Huet B, Auchus RJ, Vongpatanasin W.

J Clin Endocrinol Metab. 2009 Apr;94(4):1361-6. doi: 10.1210/jc.2008-2660. Epub 2009 Jan 21.

2.

Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug.

Shafiq MM, Menon DV, Victor RG.

Am J Med. 2008 Apr;121(4):265-71. doi: 10.1016/j.amjmed.2007.11.016. Review.

3.

Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activation and vasoconstriction in humans.

Menon DV, Wang Z, Fadel PJ, Arbique D, Leonard D, Li JL, Victor RG, Vongpatanasin W.

J Am Coll Cardiol. 2007 Aug 14;50(7):626-33. Epub 2007 Jul 30.

4.

Epithelial sodium channel allele T594M is not associated with blood pressure or blood pressure response to amiloride.

Hollier JM, Martin DF, Bell DM, Li JL, Chirachanchai MG, Menon DV, Leonard D, Wu X, Cooper RS, McKenzie C, Victor RG, Auchus RJ.

Hypertension. 2006 Mar;47(3):428-33. Epub 2006 Jan 23.

5.

Effects of transdermal estrogen replacement therapy on cardiovascular risk factors.

Menon DV, Vongpatanasin W.

Treat Endocrinol. 2006;5(1):37-51.

PMID:
16396517

Supplemental Content

Loading ...
Support Center